Bright Minds Biosciences

CNX:DRUG · CA10919W4056

BiotechnologySmall

360° View

Value61

Price/Sales—

Price/Earnings81

Price/Book38

Dividend Yield1

Growth57

Revenue Growth—

Profit Growth73

Capital Growth8

TSR 52w78

Safety94

Leverage100

Liquidity26

Refinancing87

Combined82

Sentiment81

Analyst Opinions74

Pro Holdings57

Opinion Changes50

Market Pulse78

Profile

CountryUSA

IndustryBiotechnology

SizeSmall

TypePublic Company

ExchangeCNSX

Founded2019

Employees12

Websitebrightmindsbio.com

ISINCA10919W4056

Last UpdateApr 2, 2026

Index & Theme

NeurologyPsychiatryPain ManagementNeuroscienceCentral Nervous SystemPsychedelic-Based Therapy

Description

Bright Minds Biosciences Inc. (Bright Minds) is a biotechnology company dedicated to developing therapeutics to improve the lives of patients with severe and life-altering diseases. The company has two wholly owned subsidiaries: Bright Minds Bioscie…

Analysis

Bright Minds Biosciences's 360° View rank of 88 places it among the strongest overall — better than 88% of its true peers.

It's growing solidly (57) and reasonably valued (61). On safety it is very well financed (94), and the market shows strongly positive sentiment (81). Taken together, its Combined rank of 82 reads as among the strongest overall.

360° rank · history

1007550250

2026

All-time high

Jun 2026

All-time low

Mar 2026

Average rank

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023

Price/Sales

—

Price/Earnings

—

Price/Book

—

Dividend Yield

—

Value (overall)

—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Bright Minds Biosciences with its peers

Xenon Pharmaceuticals

NMQ:XENE

CountryCanada

IndustryBiotechnology

SizeSmall

Full Stock Analysis →

Larimar Therapeutics

NMQ:LRMR

CountryUSA

IndustryBiotechnology

SizeSmall

Full Stock Analysis →

Spero Therapeutics

NSQ:SPRO

CountryUSA

IndustryBiotechnology

SizeSmall

Full Stock Analysis →

ImageneBio

NAQ:IMA

CountryUSA

IndustryPharmaceuticals

SizeSmall

Full Stock Analysis →

Tyra Biosciences

NSQ:TYRA

—

CountryUSA

IndustryBiotechnology

SizeSmall

Full Stock Analysis →

BridgeBio Oncology Therapeutics

NMQ:BBOT

—

CountryUSA

IndustryBiotechnology

SizeSmall

Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View

1 · Watch OutGood· 100

Value

1 · ExpensiveGood Value· 100

Quality

1 · Weak FundamentalsHigh Quality· 100

Growth

1 · Tough TimesHigh Growth· 100

Safety

1 · High LeverageWell-Financed· 100

Sentiment

1 · SkepticismPositive· 100

Learn More →